YAHAIRA SANCHEZ: Open Payments
NPI 1336806710 · TEMECULA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,878 in 84 payments from 14 companies in 2025. Trend: 2023 $1,037 · 2024 $1,252 · 2025 $1,878
Food & beverage: $1,878
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 17 | $549 |
| ABBVIE INC. | 33 | $528 |
| Madrigal Pharmaceuticals | 10 | $365 |
| Phathom Pharmaceuticals, Inc. | 8 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $57 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $56 |
| Echosens North America, Inc. | 2 | $50 |
| Janssen Biotech, Inc. | 2 | $44 |
| QOL Medical, LLC | 2 | $38 |
| Gilead Sciences, Inc. | 1 | $21 |
Products named: IBSRELA, REZDIFFRA, RINVOQ, LINZESS, VOQUEZNA, MAVYRET, VIBERZI, ENTYVIO.
Industry payments across CA — which companies pay providers there.
